SBI Securities’s Hepion Pharmaceuticals HEPA Stock Holding History

SBI Securities’s Portfolio HEPA Stock Details HEPA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-32	Closed	-$14	–	4181
2025 Q1	$14	Buy	32 +29	+967%	+$283	﹤0.01%	3916
2024 Q4	$59	Buy	+3	New	+$94	﹤0.01%	3601

Other funds holding HEPA

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

SBI Securities's HEPA Position: Q2 2025 in Review

SBI Securities sold out of Hepion Pharmaceuticals (HEPA) in Q2 2025, closing a stake of 32 shares — an estimated $14 sold.

SBI Securities first reported a position in HEPA in Q4 2024 and held it in 2 quarters. The position peaked at $59 in Q4 2024. 4 funds tracked by Wall St. Rank hold HEPA as of Q2 2025.

SBI Securities reported no remaining Hepion Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
SBI Securities sold 32 Hepion Pharmaceuticals shares in Q2 2025, an estimated $14.
SBI Securities first reported a position in Hepion Pharmaceuticals in Q4 2024 and held it in 2 quarters.
SBI Securities's Hepion Pharmaceuticals position peaked at $59 in Q4 2024.
4 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q2 2025.

Based on SBI Securities's 13F filing for Q2 2025, filed 8 Aug 2025.